The Latest: Idaho directing $10M toward hospitals, clinics
BOISE, Idaho — Gov. Brad Little says $10 million in relief funds will be directed to Idaho hospitals, primary care providers, urgent care clinics and skilled nursing facilities because of the surge in COVID-19 patients.
Little announced the additional money on Tuesday, saying the funds will help ease the burden on hospitals and other health care providers. The number of people hospitalized with coronavirus has been steadily increasing, with a record of at least 717 patients reported statewide last week.
With a record number of COVID-19 patients in Idaho’s intensive care units, the state recently entered a “crisis standards of care” designation that allows hospitals to begin health care rationing as needed.
Nearly all new cases, hospitalizations and deaths have been among unvaccinated residents, the governor’s office says. Idaho’s vaccination rate remains one of lowest in the nation, with only about half of the eligible residents fully vaccinated.
MORE ON THE PANDEMIC:
— Johnson & Johnson: Booster dose provides strong response
— China keeps virus at bay, at high cost, ahead of Olympics
— U.S. ramping up rapid COVID-19 tests for home, school
— Q&A: America’s new COVID-19 rules for international travel
— See AP coverage at https://apnews.com/hub/coronavirus-pandemic
HERE’S WHAT ELSE IS HAPPENING:
BOWLING GREEN, Ohio — U.S. Rep. Bob Latta is the second member of Congress from Ohio to test positive this week for the coronavirus, despite being vaccinated.
The Republican lawmaker from the 5th Congressional District announced Tuesday he contracted the virus after he was exposed to someone who also tested positive. He says he’s experiencing no symptoms and will work from home.
Latta’s tweet came shortly after U.S. Rep. Tim Ryan announced he had also joined the list of more than 80 members of Congress who have contracted the virus since the start of the pandemic, according to an Associated Press analysis.
A spokeswoman for Latta said Ryan and Latta had not been in close contact.
Ryan, the Democratic frontrunner for Republican Rob Portman’s seat, says he’ll work remotely until he can safely return to Washington.
WASHINGTON — President Joe Biden is betting on millions more rapid, at-home tests to help curb the latest deadly wave of the COVID-19 pandemic.
Surging infections are overloading hospitals and threatening to shutter some classrooms. However, the tests are quickly disappearing from pharmacy shelves in many parts of the U.S., and manufacturers say it will take them weeks to ramp up production. Production was decreased after demand for the tests plummeted in early summer.
The large commercial labs that process most tests performed at hospitals and testing sites report plenty of capacity. LabCorp, one of the biggest laboratory chains, said last week it was delivering results for 150,000 tests daily, with the ability to double that number.
Rapid tests can be done anywhere and have a 20-minute turnaround time, but most school testing programs still rely on tests processed in labs, which return results in a day or two.
The Department of Health and Human Services announced a $2 billion plan to purchase rapid tests. For now, retail chains like CVS and Walgreens have placed limits on how many at-home tests customers can buy.
Abbott Laboratories, the country’s largest rapid test maker, says it is currently producing “tens of millions” of its BinaxNOW tests per month and working to increase capacity in the coming weeks.
BUCHAREST, Romania — Romania’s chief vaccination coordinator says vulnerable people likely will start receiving third vaccine doses against COVID-19 next week.
Romania reported 6,789 new daily cases on Tuesday, the highest number since December. The increased cases and waning vaccinations are putting a strain on the health care system.
“The focus must remain on increasing rate vaccination coverage,” chief vaccination coordinator Valeriu Gheorghita says, “while enhancing the immune response of vulnerable people who have already received the first vaccination.”
The boosters will target people at risk of developing severe forms of disease from COVID-19, as well as critical workers such as medical staff. A decision on the third shots will be made in the coming days, he says.
Romania has recorded more than 1.1 million confirmed infections and 35,721 confirmed deaths.
BEIJING — China’s “zero tolerance” strategy of trying to isolate every case and stop transmission of the coronavirus has kept the country of 1.4 billion people largely free of the disease.
But the public and businesses are paying a steep price. The government has renewed city lockdowns and travel controls in some areas to quash outbreaks that began in July. Most of China is open for travel, but tourists are reluctant to risk getting caught in a lockdown. That led to a slump in August consumer spending.
International athletes are due to compete in the Winter Olympics in Beijing in February, but authorities haven’t said if spectators from abroad will be allowed into the country.
China has reported 4,636 confirmed deaths — none since February — and 95,577 confirmed cases since early 2020. The total reported cases is smaller than one-day new infections in the United States, India and some other countries.
NEW DELHI — India says the British government’s decision not to recognize coronavirus vaccine certificates issued by Indian authorities is a “discriminatory policy” that will impact its citizens who want to travel to that country.
Foreign Secretary Harsh Vardhan Shringla says the new rules could force India to “impose reciprocal measures” if the matter is not resolved.
The new rules require Indians visiting the U.K to quarantine themselves for 10 days and undergo COVID-19 tests even if they are fully vaccinated with AstraZeneca vaccines made under license in India.
The rules take effect next month. India’s Serum Institute, which makes the AstraZeneca vaccine, has not applied for its approval by the European Union.
Most people in India have been vaccinated with the Indian-made AstraZeneca vaccine. Others have received COVAXIN, which is not used in Britain.
India, the world’s largest vaccine producer, said Monday it will resume exports and donations of surplus coronavirus vaccines in October after a several-month freeze due to a massive surge in domestic infections.
WARSAW, Poland — Poland’s government is recommending a third dose of vaccine to medical workers and people over age 50.
Deputy Health Minister Waldemar Kraska says the third dose is recommended after six months from the full immunization, also with the one-shot Johnson & Johnson vaccines. The booster will be administered with Pfizer and Moderna products, which health experts say can be mixed with other vaccines.
Registration for the third dose will start Sept. 24.
In Poland, more than 19 million of the 38 million population have been fully immunized. There have been more than 75,500 confirmed deaths.
BANGKOK — Health officials in Bangkok have made headway in their effort to vaccinate children against the coronavirus, giving shots of the Pfizer vaccine to students ages 12 to 18 with underlying diseases.
Vaccinations for that age group were first offered last month through hospitals, but now are being arranged by schools. A separate campaign by a medical research institute on Monday began inoculating children aged 10 to 18 with China’s Sinopharm vaccine.
On Tuesday, 1,500 students received shots of the Pfizer vaccine, 800 for the first time and 700 as a follow-up to their first shot in August.
The Health Ministry plans to give Pfizer shots to all students ages 12 to 18 nationwide on Oct. 4, starting with the 29 provinces most affected by the coronavirus, including Bangkok. About 41% of the population is fully vaccinated.
The Health Ministry on Tuesday announced 10,919 cases and 143 deaths, bringing the totals to 1.5 million confirmed cases and 15,612 confirmed deaths.
COLOMBO, Sri Lanka — Sri Lankan health officials say more than 50% of the island nation’s 22 million people are fully vaccinated.
According to the health ministry latest statistics, 11.1 million of the 22 million population have been fully inoculated with the COVID-19 vaccines. Sri Lanka expedited the inoculation drive two months ago when the number of positive cases and deaths began surging due to the rapid spreading of the delta variant.
Sri Lanka has been using Sinopharm, AstraZeneca, Pfizer, Moderna and Sputnik V vaccines. The health ministry plans inoculate citizens above 20 years old by the end of October.
When the spike came in July, daily positive cases surpassed 3,000. The number is now below 2,000. Sri Lanka has registered 504,491 confirmed cases and 12,125 confirmed deaths.
HELSINKI — Finland plans to vaccinate all people over age 12 for a third time with a coronavirus vaccine shot after getting the expected approval from a state health panel later this year.
Finland has already entered into a procurement agreement for coronavirus vaccines, according to the minister for family affairs and social services Krista Kiuru. Booster shots are currently offered in Finland only to the estimated 50,000 people suffering from severely weakened immune systems, including cancer patients and people who have received organ transplants.
Hanna Nohynek, the chief physician for the Finnish Institute for Health and Welfare, says the third dose of the COVID-19 vaccine is expected to cause similar side effects.
Some 73% of Finland’s entire population have received a first coronavirus vaccine shot and 59% have gotten the second shot.
ISTANBUL — Turkish Health Minister Fahrettin Koca says more than half of the country is fully vaccinated against COVID-19.
“Our success against the epidemic will increase as the rate of two doses and full vaccination rises,” he tweeted. Health Ministry figures show 42.3 million second doses have been given from a total population of 83.6 million.
Daily rates of infection remain at more than 20,000 a day, having surged after the easing of restrictions in July. There were 27,688 confirmed cases and 231 confirmed deaths reported on Monday.
LONDON — Johnson & Johnson released data showing that a booster dose to its one-shot coronavirus vaccine provides a strong immune response months after people receive a first dose.
J&J said in a statement Tuesday that it ran two early studies in people previously given its vaccine and found that a second dose produced an increased antibody response in adults from age 18 to 55. The study’s results haven’t yet been peer-reviewed.
While the single-dose vaccine remains strongly effective, “a booster shot further increases protection against COVID-19 and is expected to extend the duration of protection significantly,” Dr. Paul Stoffels, J&J’s chief scientific officer, said in a statement.
The company previously published data showing its one-shot dose provided protection for up to eight months after immunization. It also pointed to recent real-world data showing 79% protection against coronavirus infection and 81% protection against COVID-19 hospitalization in the U.S., even as the contagious delta variant began spreading.
The company is in talks with regulators including the U.S. Food and Drug Administration, the European Medicines Agency and others regarding using booster doses of its vaccine.
MELBOURNE, Australia — Hundreds of demonstrators have marched in the streets of Australia’s second-largest city to protest against mandatory coronavirus vaccine rules in the construction industry.,
The protest Tuesday in Melbourne was aimed at a Victoria state government mandate requiring all construction workers to get vaccinated.
The march came a day after riot police were called in to disperse about 500 protesters who smashed the door at the offices of the Construction, Forestry, Maritime, Mining and Energy Union, which represents construction workers.
On Monday night, the state government announced that the construction industry would be shut down from Tuesday for two weeks in metropolitan Melbourne and some regional areas.
Officials say all worksites will need to demonstrate compliance with health directions prior to reopening, including that staff have had at least one dose of a vaccine before they return to work Oct. 5.